XML 54 R41.htm IDEA: XBRL DOCUMENT v3.2.0.727
Commitments and Contingencies - Additional Information (Detail)
€ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2015
USD ($)
Jun. 30, 2014
USD ($)
Jun. 30, 2015
USD ($)
Jun. 30, 2014
USD ($)
Jun. 30, 2015
EUR (€)
Dec. 31, 2014
USD ($)
Aug. 31, 2013
USD ($)
Aug. 31, 2013
EUR (€)
May. 31, 2013
USD ($)
Sale Leaseback Transaction [Line Items]                  
Accrued in other current liabilities $ 10,070,000   $ 10,070,000     $ 8,043,000      
Company had royalty and license expenses relating to those agreements 200,000 $ 0 400,000 $ 500,000          
Payment of contingent consideration     129,000 1,109,000          
Current portion of contingent consideration 599,000   599,000     733,000      
Contingent consideration non-current portion 5,009,000   5,009,000     5,023,000      
Research and development milestones [Member]                  
Sale Leaseback Transaction [Line Items]                  
Milestone payments paid 500,000 $ 0 900,000 300,000          
BioHelix [Member]                  
Sale Leaseback Transaction [Line Items]                  
Payments for Royalties 0   100,000 $ 49,000          
Current portion of contingent consideration 600,000   600,000            
Contingent consideration non-current portion 4,900,000   4,900,000            
BioHelix [Member] | Minimum [Member]                  
Sale Leaseback Transaction [Line Items]                  
Contingent consideration                 $ 5,000,000
BioHelix [Member] | Maximum [Member]                  
Sale Leaseback Transaction [Line Items]                  
Contingent consideration                 $ 13,000,000
Andiatec Acquisition [Member]                  
Sale Leaseback Transaction [Line Items]                  
Current portion of contingent consideration 25,000   25,000            
Contingent consideration non-current portion 100,000   100,000            
Andiatec Acquisition [Member] | Research and development milestones [Member]                  
Sale Leaseback Transaction [Line Items]                  
Contingent consideration 3,400,000   3,400,000   € 3.0        
Andiatec Acquisition [Member] | Maximum [Member]                  
Sale Leaseback Transaction [Line Items]                  
Contingent consideration             $ 600,000 € 0.5  
Claims and litigation [Member]                  
Sale Leaseback Transaction [Line Items]                  
Accrued in other current liabilities 300,000   300,000     300,000      
Research and Development Agreements [Member]                  
Sale Leaseback Transaction [Line Items]                  
Current commitments $ 2,400,000   $ 2,400,000     $ 4,300,000